Aquatic vaccines—current status and developing prospects

The global aquaculture industry faces significant challenges due to the increasing prevalence of infectious diseases that threaten fish health and productivity. Vaccination has emerged as a critical strategy to mitigate these risks, enhancing the overall resilience of aquatic species. This chapter explains into the historical context of aquatic vaccines, tracing their evolution from traditional methods to cutting-edge biotechnological innovations. Aquatic vaccines play a pivotal role in enhancing the health and productivity of aquaculture species. This chapter provides a comprehensive overview of the current status of aquatic vaccines, highlighting their development, application, and efficacy in combating prevalent aquatic diseases. It explores the challenges faced in vaccine formulation and delivery, including antigen selection, adjuvant utilization, and the unique physiological characteristics of aquatic organisms. Furthermore, the chapter discusses emerging technologies such as DNA and RNA vaccines, recombinant proteins, and the potential of nanotechnology in vaccine development. By evaluating the existing literature and recent advancements, this chapter aims to illustrate the future prospects of aquatic vaccines, underscoring their significance in sustainable aquaculture practices and food security. The future of aquatic vaccines is promising, with ongoing research aimed at harnessing genetic engineering, genomics, and proteomics to design next-generation vaccines. Collaborations between academic institutions, industry stakeholders, and regulatory bodies will be vital in translating scientific discoveries into practical applications. The chapter concludes by discussing the importance of sustainable aquaculture practices, emphasizing how effective vaccination strategies can contribute to food security and the economic viability of aquaculture enterprises worldwide.